4.6 Article

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Infectious Diseases

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Editorial Material Critical Care Medicine

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

Fabio S. Taccone et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Medicine, General & Internal

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Joshua Geleris et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Immunology

The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms

Petra Zimmermann et al.

FRONTIERS IN IMMUNOLOGY (2018)